Skip to main content

1 September 2026

Last updated: Sunday 30 August 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A Big Pharma deal that shares risk and reward

Friday 27 April 2012

Interviewee/Contributor

Bahija Jallal

Organisation

MedImmune

Organisations

University of Nottingham and Nottingham University NHS Trust
Biophytis SA
NEO New Oncology AG
Shore Capital Ltd
Index Ventures
Silence Therapeutics Plc
Quell Therapeutics Ltd
Cellectis SA
Alpine Institute for Drug Discovery
AlzeCure Pharma AB

Interviewees and Contributers

Henrik Jensen
Christian Grøndahl
Rob Meijer and Ilona Enninga
Michael L Roberts
Jack Barbut
Todd Sherer
Alexander Gebauer
Gerald Möller
Christophe Bonny
Richard Goodfellow

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

OncoOne forms SAB

Sunday 30 August 2026

New senior executives at Moberg Pharma

Sunday 30 August 2026

Immunic names biopharma builder to board

Sunday 30 August 2026

New chief business officer at Lytix Biopharma

Sunday 30 August 2026

Reacta Healthcare appoints head of R&D

Sunday 30 August 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form